Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | ethanolamine | 2015 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 9745 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 9812 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 10093 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 10640 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
GC POSITIVE ION MODE | ethanolamine | 11547 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 13506 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 13723 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 13734 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 13898 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 13935 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
GC POSITIVE ION MODE | ethanolamine | 14056 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 14453 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
GC POSITIVE ION MODE | ethanolamine | 14545 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 14699 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 15171 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | ethanolamine | 15210 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | ethanolamine | 15878 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | ethanolamine | 17066 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | ethanolamine | 18979 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
GC POSITIVE ION MODE | ethanolamine | 19259 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 20293 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | ethanolamine | 20306 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 21690 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 23853 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 23987 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | ethanolamine | 26537 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 26970 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 29862 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 30462 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 30993 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 31220 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 31740 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | ethanolamine | 32494 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 32990 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 33754 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | ethanolamine | 33761 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 34492 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 34932 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 35118 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 35736 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 35924 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
GC POSITIVE ION MODE | ethanolamine | 35985 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 36306 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 36620 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 37292 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
GC POSITIVE ION MODE | ethanolamine | 39489 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | ethanolamine | 41632 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
GC POSITIVE ION MODE | ethanolamine | 47817 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 51482 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
GC POSITIVE ION MODE | ethanolamine | 54424 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
GC POSITIVE ION MODE | ethanolamine | 64285 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 70818 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
GC POSITIVE ION MODE | ethanolamine | 74156 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |